After Two Years in Ultra-Stealth Mode, 454 Unveils Technology at GSAC | GenomeWeb

BOSTON, Oct. 2 - At a panel discussion on this GSAC kickoff evening, attendees finally got a notion of what CuraGen subsidiary 454 is up to. Two years of industry buzzing paid off as Michael Weiner, 454's vice president of molecular sciences, spoke at a panel entitled "The Future of Sequencing: Advancing Toward the $1,000 Genome."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.